Modulators of cystic fibrosis transmem- brane conductance regulator

Details for Australian Patent Application No. 2008256717 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Zhou, Jinglan; Hadida Ruah, Sara; Binch, Hayley; Grootenhuis, Peter

Agent Baldwins

Pub. Number AU-A-2008256717

PCT Pub. Number WO2008/147952

Priority 60/931,775 25.05.07 US; 60/968,704 29.08.07 US

Filing date 23 May 2008

Wipo publication date 4 December 2008

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2008/147952 Priority application(s): WO2008/147952

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008256727-Antiviral drugs for treatment or prevention of dengue infection

2008256714-Fingertip mouse and base